Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Jaguar Animal Health Free Cash Flow 2014-2024 | JAGX

Jaguar Animal Health free cash flow from 2014 to 2024. Free cash flow can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures.
  
Jaguar Animal Health Annual Free Cash Flow
2023 -33.24
2022 -33.18
2021 -34.98
2020 -15.29
2019 -20.46
2018 -22.74
2017 -9.83
2016 -14.52
2015 -14.32
2014 -5.41
2013 -0.34
Jaguar Animal Health Quarterly Free Cash Flow
2024-03-31 -7.05
2023-12-31 -33.24
2023-09-30 -25.79
2023-06-30 -19.00
2023-03-31 -9.95
2022-12-31 -33.18
2022-09-30 -26.76
2022-06-30 -19.41
2022-03-31 -7.70
2021-12-31 -34.98
2021-09-30 -26.05
2021-06-30 -16.62
2021-03-31 -6.71
2020-12-31 -15.29
2020-09-30 -11.22
2020-06-30 -8.31
2020-03-31 -4.30
2019-12-31 -20.46
2019-09-30 -17.32
2019-06-30 -8.78
2019-03-31 -3.47
2018-12-31 -22.74
2018-09-30 -17.84
2018-06-30 -15.03
2018-03-31 -9.63
2017-12-31 -9.83
2017-09-30 -4.50
2017-06-30 -1.47
2017-03-31 -0.29
2016-12-31 -14.52
2016-09-30 -11.79
2016-06-30 -8.40
2016-03-31 -4.61
2015-12-31 -14.32
2015-09-30 -10.39
2015-06-30 -7.03
2015-03-31 -1.34
2014-12-31 -5.51
2014-09-30 -3.67
2014-06-30 -1.83
2014-03-31 -0.61
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.047B $0.010B
Jaguar Health, Inc. is a natural-products pharmaceuticals company. It focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals. The company through its subsidiary Napo Pharmaceuticals Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its product pipeline consists of Mytesi(R), Canalevia(TM), Equilevia(TM) and Neonorm (TM). Jaguar Health Inc., formerly known as Jaguar Animal Health Inc., is based in San Francisco, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $79.573B 32.35
Chugai Pharmaceutical (CHGCY) Japan $52.837B 23.62
Takeda Pharmaceutical (TAK) Japan $42.029B 8.51
Merck (MKGAF) Germany $23.651B 22.93
Astellas Pharma (ALPMY) Japan $17.445B 27.54
Sandoz Group AG (SDZNY) Switzerland $15.171B 0.00
Neurocrine Biosciences (NBIX) United States $14.255B 39.02
Shionogi (SGIOY) Japan $13.463B 11.70
United Therapeutics (UTHR) United States $12.183B 12.99
Catalent (CTLT) United States $9.954B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.661B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.847B 7.53
Revolution Medicines (RVMD) United States $6.604B 0.00
Ionis Pharmaceuticals (IONS) United States $5.652B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.946B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.992B 0.00
Summit Therapeutics (SMMT) United States $3.187B 0.00
Dyne Therapeutics (DYN) United States $3.092B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.083B 0.00
PTC Therapeutics (PTCT) United States $3.077B 0.00
Corcept Therapeutics (CORT) United States $3.007B 27.25
Indivior (INDV) United States $2.356B 11.17
Recursion Pharmaceuticals (RXRX) United States $2.295B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.077B 11.81
Catalyst Pharmaceuticals (CPRX) United States $1.999B 19.45
Evotec AG (EVO) Germany $1.846B 0.00
Ardelyx (ARDX) United States $1.845B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.831B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.785B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.594B 23.97
Soleno Therapeutics (SLNO) United States $1.571B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.509B 0.00
Xencor (XNCR) United States $1.464B 0.00
Pacira BioSciences (PCRX) United States $1.425B 13.54
4D Molecular Therapeutics (FDMT) United States $1.344B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.265B 0.00
Enliven Therapeutics (ELVN) United States $1.129B 0.00
Collegium Pharmaceutical (COLL) United States $1.117B 6.68
Cronos Group (CRON) Canada $1.062B 0.00
Cassava Sciences (SAVA) United States $1.060B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.005B 15.66
Ocular Therapeutix (OCUL) United States $0.974B 0.00
USANA Health Sciences (USNA) United States $0.927B 15.15
Relay Therapeutics (RLAY) United States $0.900B 0.00
ARS Pharmaceuticals (SPRY) United States $0.890B 0.00
ProKidney (PROK) United States $0.890B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.876B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.825B 0.00
Silence Therapeutics (SLN) United Kingdom $0.699B 0.00
Lyell Immunopharma (LYEL) United States $0.681B 0.00
Sage Therapeutics (SAGE) United States $0.673B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.655B 0.00
Exscientia (EXAI) United Kingdom $0.627B 0.00
Harrow (HROW) United States $0.594B 0.00
Savara (SVRA) United States $0.576B 0.00
Altimmune (ALT) United States $0.570B 0.00
Siga Technologies (SIGA) United States $0.537B 6.86
Corbus Pharmaceuticals Holdings (CRBP) United States $0.519B 0.00
OmniAb (OABI) United States $0.514B 0.00
Heron Therapeutics (HRTX) United States $0.512B 0.00
Korro Bio (KRRO) United States $0.506B 0.00
KalVista Pharmaceuticals (KALV) United States $0.501B 0.00
Verve Therapeutics (VERV) United States $0.500B 0.00
Bioventus (BVS) United States $0.493B 18.88
Esperion Therapeutics (ESPR) United States $0.470B 0.00
Larimar Therapeutics (LRMR) United States $0.464B 0.00
Lexeo Therapeutics (LXEO) United States $0.454B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.443B 0.00
Tourmaline Bio (TRML) United States $0.373B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.369B 0.00
Organogenesis (ORGO) United States $0.367B 69.25
Nanobiotix S.A (NBTX) France $0.341B 0.00
Fractyl Health (GUTS) United States $0.334B 0.00
Nektar Therapeutics (NKTR) United States $0.321B 0.00
Xeris Biopharma Holdings (XERS) United States $0.304B 0.00
Aquestive Therapeutics (AQST) United States $0.290B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.95
ESSA Pharma (EPIX) Canada $0.277B 0.00
Black Diamond Therapeutics (BDTX) United States $0.276B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.264B 0.00
Foghorn Therapeutics (FHTX) United States $0.256B 0.00
Metagenomi (MGX) United States $0.251B 0.00
Pyxis Oncology (PYXS) United States $0.247B 0.00
Akebia Therapeutics (AKBA) United States $0.241B 0.00
Aldeyra Therapeutics (ALDX) United States $0.239B 0.00
Eliem Therapeutics (ELYM) United States $0.239B 0.00
Prelude Therapeutics (PRLD) United States $0.226B 0.00
Conduit Pharmaceuticals (CDT) United States $0.215B 0.00
Avita Medical (RCEL) United States $0.211B 0.00
Profound Medical (PROF) Canada $0.201B 0.00
Adherex Technologies (FENC) United States $0.200B 243.67
Galectin Therapeutics (GALT) United States $0.196B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Century Therapeutics (IPSC) United States $0.194B 0.00
CytoDyn (CYDY) United States $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.194B 0.00
Telomir Pharmaceuticals (TELO) United States $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Achieve Life Sciences (ACHV) Canada $0.174B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.167B 0.00
MediWound (MDWD) Israel $0.164B 0.00
Incannex Healthcare (IXHL) Australia $0.162B 0.00
VAXART, INC (VXRT) United States $0.159B 0.00
Elite Pharmaceuticals (ELTP) United States $0.158B 14.78
Context Therapeutics (CNTX) United States $0.149B 0.00
Cardiol Therapeutics (CRDL) Canada $0.149B 0.00
OptiNose (OPTN) United States $0.136B 0.00
Karyopharm Therapeutics (KPTI) United States $0.134B 0.00
Regulus Therapeutics (RGLS) United States $0.132B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.125B 8.36
FibroGen (FGEN) United States $0.119B 0.00
Citius Pharmaceuticals (CTXR) United States $0.119B 0.00
PMV Pharmaceuticals (PMVP) United States $0.114B 0.00
Vivani Medical (VANI) United States $0.101B 0.00
ProPhase Labs (PRPH) United States $0.100B 0.00
SCYNEXIS (SCYX) United States $0.099B 1.39
Assertio Holdings (ASRT) United States $0.099B 4.52
Relmada Therapeutics (RLMD) United States $0.098B 0.00
AlloVir (ALVR) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Aclaris Therapeutics (ACRS) United States $0.085B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.074B 0.00
Tempest Therapeutics (TPST) United States $0.073B 0.00
Journey Medical (DERM) United States $0.068B 0.00
Champions Oncology (CSBR) United States $0.065B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.064B 0.00
Protara Therapeutics (TARA) United States $0.062B 0.00
Carisma Therapeutics (CARM) United States $0.059B 0.00
Nutriband (NTRB) United States $0.053B 0.00
BioLineRx (BLRX) Israel $0.050B 0.00
Inotiv (NOTV) United States $0.048B 0.00
Gain Therapeutics (GANX) United States $0.045B 0.00
NRx Pharmaceuticals (NRXP) United States $0.043B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.043B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
CASI Pharmaceuticals (CASI) China $0.042B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.040B 0.00
Unicycive Therapeutics (UNCY) United States $0.040B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Lipocine (LPCN) United States $0.034B 0.00
DURECT (DRRX) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.032B 0.00
Surrozen (SRZN) United States $0.030B 0.00
JanOne (JAN) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Oncternal Therapeutics (ONCT) United States $0.025B 0.00
Aptorum Group (APM) United Kingdom $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.024B 0.00
Lyra Therapeutics (LYRA) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
PolyPid (PYPD) Israel $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 0.79
Indaptus Therapeutics (INDP) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Talphera (TLPH) United States $0.018B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.018B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Alaunos Therapeutics (TCRT) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
CERo Therapeutics Holdings (CERO) United States $0.016B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.015B 0.00
Mannatech (MTEX) United States $0.015B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.011B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
TransCode Therapeutics (RNAZ) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
SHINECO (SISI) China $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Avenue Therapeutics (ATXI) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.60
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 34.15